CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,634 | -75.9% | 135,947 | -70.3% | 0.01% | -76.0% |
| Q2 2023 | $25,656,428 | +3503.4% | 457,008 | +4095.4% | 0.05% | +2400.0% |
| Q3 2022 | $712,000 | -97.5% | 10,893 | -95.7% | 0.00% | -98.3% |
| Q3 2021 | $28,624,000 | +35238.3% | 255,727 | +13240.0% | 0.12% | +11800.0% |
| Q1 2020 | $81,000 | -44.1% | 1,917 | -19.3% | 0.00% | 0.0% |
| Q4 2019 | $145,000 | -31.6% | 2,374 | -48.7% | 0.00% | -88.9% |
| Q1 2018 | $212,000 | – | 4,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |